Atlas Trials

Evaluation of the Level of Expression of CD45RC on T Lymphocytes as a Predictive Biomarker of Acute Rejection After Renal Transplantation

Clinical trial NCT03994497 · UNKNOWN

Trial details

NCT number
NCT03994497
Sponsor
University Hospital, Angers
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
End-stage Renal Disease
Start date
2021-02-03
Primary completion
2025-02-02
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.